New Therapy Marks A Milestone In Fight Against Cystic Fibrosis
Originally posted in Cystic Fibrosis News From Medical News Today
Results of the pivotal Phase 3 clinical trial published in the Nov. 3, 2011 New England Journal of Medicine, find that the oral medication ivacaftor (VX-770) provides major, sustained improvement in lung function, growth and other signs and symptoms for cystic fibrosis (CF) patients…
No Comments »
RSS feed for comments on this post. TrackBack URL
by Raelene
